Tag: Ophthalmology
Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Speedy Vitamin Debuts ecommerce Website to Help Rising International Demand for Well being and...
LONDON, UK / ACCESSWIRE / July 12, 2021 / After his successful Amazon shop Rapid Nutrition PLC (Euronext Growth Paris: ALRPD) (OTCQB:RPNRF), a naturopathic...
